Connect with us

Broadcasting

AstraZeneca and Partners Launch Transformative Cancer Care Africa Programme in Kenya

Published

on

Kindly share this post

AstraZeneca has launched Cancer Care Africa programme in Kenya, a first-of-its-kind collaboration with the Ministry of Health, The Kenya Society of Haematology and Oncology (KESHO), Axios, the National Cancer Institute of Kenya (NCI), and other partners to improve cancer care in Kenya by equitably improving access and outcomes across the patient care pathway, from diagnosis through to treatment and beyond.

Through a co-creation approach, the initiative will foster collaboration among the oncology community. Hon. Nakhumicha S. Wafula EGH, Cabinet Secretary for Health, Kenya, Dr Elias Melly, CEO, National Cancer Institute of Kenya and Dave Fredrickson, Executive Vice-President, Oncology Business Unit, AstraZeneca attended an event today in Nairobi, Kenya marking the launch of this program.

Cancer has become a major public health concern in Kenya and across Africa. Latest figures from the World Health Organization show there were 44,726 cancer cases and 29,317 cancer deaths in Kenya in 2022. This is set against a regional context that estimates 2.1 million new cases and 1.4 million deaths annually by 2040 across Africa.

Despite recent increases in resources invested in cancer, several critical barriers still hinder progress including a lack of disease awareness, limited diagnostic capabilities, an absence of structured screening programmes, and challenges in accessing treatment. To tackle these barriers, each country we work with develops initiatives across our four pillars of action:

  • Building Capacity and Capabilities: We are committed to supporting more than
    100 oncology centres and providing training for more than 10,000 healthcare professionals to improve quality of care delivered to patients across the continent.
  • Enhancing screening and diagnostics: We will enhance screening and diagnostics provision for one million people across lung, breast and prostate cancer, to improve patient outcomes and reduce health system burden through acting early approaches.
  • Empowering patients: We will ensure we address the real needs of patients through engagement with local PAGs to support increased disease awareness and informed patient decision-making.
  • Enabling access to medicines: We will enhance the availability of critical cancer medicines by introducing flexible models that can provide access to our innovative treatments.

Ahead of the launch, Cancer Care Africa has already donated ultrasound biopsy machines to seven hospitals across Kenya to enhance early prostate cancer diagnosis, as well as donating the country’s first biomarker testing machine for epidermal growth factor receptor (EGFR) mutations to Aga Khan University Hospital.

Hon. Nakhumicha S. Wafula EGH, Cabinet Secretary for Health, Kenya, said, “The launch of the Cancer Care Africa programme in Kenya is a significant step towards improving cancer care for all. This collaborative initiative has the potential to significantly improve access to diagnosis, treatment, and care, ultimately saving lives and improving the well-being of Kenyans impacted by this disease, as well as their families and communities.”

Dave Fredrickson, Executive Vice-President, Oncology Business Unit, AstraZeneca, said: “With an increasing number of patients being diagnosed with cancer in Kenya and across Africa in the coming decades, joint action to improve patient outcomes and safeguard health care systems for the future has never been more important. The Cancer Care Africa programme will support early detection, increase timely diagnosis, and improve access to treatment options for patients across Kenya.”

Launched in November 2002 at COP27 in Egypt, Cancer Care Africa is aiding countries across the continent to fight against cancer by advocating for policy changes to enhance screening and diagnostics, implementing health awareness and education programs to empower patients, as well as training physicians and healthcare workers and building their capacities, and striving to enable access to cancer medicines. With these pillars, Cancer Care Africa strives to improve outcomes for all individuals affected by the disease, irrespective of their demographic, geographic, or socio-economic status.


Kindly share this post

Ugo Onwuaso is an ICT enthusiast. He believes technology should be used for general good. He holds a Master of Public Administration (MPA) degree from the Lagos state University. Dear Reader, Your support matters. But we believe that technology makes life more exciting and helps improve the lives of people around Nigeria and indeed the world. That is why, we have devoted our energy to independent reportage of technology and finance and how they affect lives. Our incisive and analytical view of how technology news affects the daily life help individuals and organizations make up their minds. Quality journalism costs money. Today, we're asking that you support us to do more. Kindly support our effort to deliver technology and finance journalism to everyone in the world. Donate as little as N1,000. Bank transfers can be made to: UBA Plc 1017156876 Communication Week Media Ltd

Broadcasting

NAFDAC’s Fight Against Counterfeit Drugs Reaches New Heights with Ibadan Raid

Published

on

Kindly share this post

National Agency for Food Drug Administration and Control (NAFDAC) on Saturday destroyed counterfeit pharmaceuticals and other products worth about N100 billion at Moniya dump sites in Ibadan, Oyo State.

The Director General of the agency, Prof. Mojisola Adeyeye, who performed the exercise at the dumpsites in the Akinyele Local Government Area (LGA) of the state, said the affected products include, Analgin, controlled substances such as Tramadol 225mg, among others.

Represented by the Director of Narcotics, Yedunni Adenuga, Adeyeye reiterated the commitment of NAFDAC to ensuring that food, drugs, cosmetics, medical devices, chemicals, packaged water, and drinks are safe, wholesome, and effective for human consumption.

She said: “The products that were classified as illicit, expired, and banned were confiscated during a raid on three markets in the country. The recent discovery of counterfeit and other products in these three major markets in the country is mind-boggling.

“Our recent enforcement activities at the Idumota, Onitsha, Ariara, and Ezeuku open drugs market were mind-boggling.

“The discoveries made of the presence of unregistered products, banned products such as Analgin, and controlled substances such as Tramadol 225mg, among others, which are part of the things making our country unsafe in terms of security.

“This operation could not have been made possible without the support of the National Security Adviser (NSA), Malam Nuhu Ribadu, who graciously approved the use of over 1,000 security personnel, including the military, police and Department of State Services (DSS).

“Today, we are witnessing the destruction of expired, falsified, controlled, unregistered, and banned medicines removed from Idumota Open Drugs outlets. The estimated street value of these products is N100 billion.

“During the three weeks exercise, several suspects were apprehended. Further investigation is being carried out, and those found culpable will be sanctioned.”

Earlier, the Director of Investigation and Enforcement, Shaba Mohammed, disclosed that raids were carried out on three markets.

Mohammed described selling drugs in the open market as an illegal and punishable act under the law.

“It is a punishable offence to sell the drugs in an open market. Also, it is illegal for people to hawk drugs inside the vehicle, kiosks, and open markets,” Mohammed explained.


Kindly share this post
Continue Reading

Broadcasting

CADEF Celebrates International Women’s Day 2025: Empowering Women and Girls with Digital Skills for a Brighter Future

Published

on

Kindly share this post

As the world marks International Women’s Day 2025, Consumer Advocacy and Empowerment Foundation (CADEF) reaffirms its commitment to bridging the gender digital divide by empowering women and girls with essential digital skills and financial inclusion opportunities. Recognizing the transformative power of digital literacy, CADEF continues to champion initiatives that equip women with the tools they need to thrive in the digital economy.

In 2024, CADEF successfully trained over 100 women and girls in digital skills, enhancing their ability to participate in the rapidly evolving digital space. Women remain underrepresented in the digital economy, with recent data from the International Telecommunication Union (ITU) indicating that 37% of women worldwide still lack access to the internet, limiting their participation in digital finance and e-commerce opportunities.

In Nigeria, the gender gap in financial inclusion persists, with a 9% disparity between men and women in access to formal financial services, according to the Enhancing Financial Innovation & Access (EFInA) report.

By addressing these disparities, CADEF aims to build on its success in 2025, scaling its digital training programs to reach even more women and girls. With digital finance playing a critical role in economic empowerment, CADEF is also committed to equipping women and girls with the knowledge and tools to navigate digital financial services effectively.

“Our vision is to create a future where no woman is left behind in the digital revolution,” said Prof. Chiso Ndukwe-Okafor, Executive Director of CADEF.

“Through our digital skills and financial literacy programs, we are not only bridging the gender gap but also enabling women to take charge of their financial futures and unlock new economic opportunities.”

As part of its 2025 efforts, CADEF is expanding its reach to underserved communities, ensuring that more women gain the skills necessary to leverage digital platforms for entrepreneurship, career advancement, and financial independence. The organization’s initiatives are aligned with global efforts to promote gender equity in the digital space, reinforcing the theme of International Women’s Day 2025: Invest in Women: Accelerate Progress.

Emphasising the commitment of the organization to the empowerment of women and girls, Lovelyn Okafor, Director of Programmes at CADEF said “We remain committed to providing women and girls with the training and resources they need to excel in an increasingly digital world. With every program we implement, we move closer to a more inclusive and empowered society.”

CADEF invites stakeholders, partners, and advocates to join in this mission of empowering women through digital skills and financial inclusion. By working together, we can build a more equitable future where women and girls have equal access to opportunities in the digital economy.


Kindly share this post
Continue Reading

Broadcasting

Tariff Hike: FG Drags MultiChoice to Court for Ignoring Regulatory Directives   

Published

on

Kindly share this post

Federal Competition and Consumer Protection Commission (FCCPC) has filed a charge against MultiChoice Nigeria Limited and John Ugbe, its chief executive officer, for allegedly violating regulatory directives and obstructing an ongoing inquiry.

Tariff Hike: FG Drags MultiChoice to Court for Ignoring Regulatory Directives    

The three counts filed before the Federal High Court Lagos, bordered on willful implementation of a price hike contrary to the Commission’s directives, an offence which violates Section 33(4) of the FCCPC Act.

The other counts are on the company’s disregard for instructions to suspend the hike in violation of Section 110, and attempt to mislead the Commission by proceeding with the increase without objection contrary to Section 159(2), and punishable under Section 159(4)(a) and (b) of the FCCPA 2018 Act.

On February 24, 2025, MultiChoice announced a price increase for its DStv and GOtv subscription packages, set to take effect on March 1, 2025.

This announcement came nearly one year after a previous price hike and sparked a public backlash, prompting the FCCPC to intervene.

On February 27, 2025, the FCCPC expressly directed MultiChoice Nigeria to maintain its current pricing structure pending the conclusion of an investigative hearing of its proposed price hike.

However, the FCCPC alleged that MultiChoice Nigeria proceeded with the price increase despite these warnings in violation of the Federal Competition and Consumer Protection Act (FCCPA) 2018.

The Commission said that by disregarding its directive and implementing the price hike before appearing before the Commission’s investigative hearing on March 6, 2025, MultiChoice has by its actions flouted regulatory processes and also demonstrated a pattern of conduct that undermines consumer rights and fair competition

In addition to the legal actions, the FCCPC disclosed that it is reviewing further enforcement measures, including potential sanctions and penalties, and regulatory interventions, to ensure compliance and accountability.

The Commission reassured Nigerians that it is committed to protecting them against exploitative business practices and ensuring that dominant players in any sector adhere to fair market principles and legal compliance.

 


Kindly share this post
Continue Reading

Trending